[
  {
    "ts": "2025-11-26T04:28:02+00:00",
    "headline": "Is Kenvue’s Share Price a Bargain After 13.5% Jump and New Product Launches?",
    "summary": "Ever wondered if Kenvue is a hidden value play or if its recent price is telling us something different? Today, we are unpacking whether the current share price is a bargain or a warning sign for investors. Kenvue’s stock price has caught some attention lately, climbing 4.9% over the last week and jumping 13.5% for the past month. This comes despite a drop of 20.0% year-to-date and 26.5% over the last year. In recent weeks, headlines have highlighted Kenvue’s continued integration efforts...",
    "url": "https://finance.yahoo.com/news/kenvue-share-price-bargain-13-042802739.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b146653e-6274-30fd-92e4-f7614c2dfcb0",
      "content": {
        "id": "b146653e-6274-30fd-92e4-f7614c2dfcb0",
        "contentType": "STORY",
        "title": "Is Kenvue’s Share Price a Bargain After 13.5% Jump and New Product Launches?",
        "description": "",
        "summary": "Ever wondered if Kenvue is a hidden value play or if its recent price is telling us something different? Today, we are unpacking whether the current share price is a bargain or a warning sign for investors. Kenvue’s stock price has caught some attention lately, climbing 4.9% over the last week and jumping 13.5% for the past month. This comes despite a drop of 20.0% year-to-date and 26.5% over the last year. In recent weeks, headlines have highlighted Kenvue’s continued integration efforts...",
        "pubDate": "2025-11-26T04:28:02Z",
        "displayTime": "2025-11-26T04:28:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2Y4xgPz6k2sJssKwLaiuQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XxQ2W.u4ql9pr6kIHenw7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-share-price-bargain-13-042802739.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-share-price-bargain-13-042802739.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T10:47:27+00:00",
    "headline": "Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3",
    "summary": "The layoffs affect Swiss manufacturing facilities. Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s amycretin helps regulate blood sugar.",
    "url": "https://www.biopharmadive.com/news/novartis-job-cuts-novos-dual-acting-diabetes-drug/806477/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "91750644-27c8-3c5c-8939-a62a974ea0d5",
      "content": {
        "id": "91750644-27c8-3c5c-8939-a62a974ea0d5",
        "contentType": "STORY",
        "title": "Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3",
        "description": "",
        "summary": "The layoffs affect Swiss manufacturing facilities. Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s amycretin helps regulate blood sugar.",
        "pubDate": "2025-11-26T10:47:27Z",
        "displayTime": "2025-11-26T10:47:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/novartis-job-cuts-novos-dual-acting-diabetes-drug/806477/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novartis-cuts-hundreds-jobs-novo-104727022.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "ARWR"
            },
            {
              "symbol": "ASND"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T09:58:51+00:00",
    "headline": "CMS covers cardiac ablation in ambulatory surgery centers",
    "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
    "url": "https://www.medtechdive.com/news/CMS-Medicare-cardiac-ablation-ASCs/806548/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "f806f0fe-d549-3b9d-994d-9754234502d1",
      "content": {
        "id": "f806f0fe-d549-3b9d-994d-9754234502d1",
        "contentType": "STORY",
        "title": "CMS covers cardiac ablation in ambulatory surgery centers",
        "description": "",
        "summary": "Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.",
        "pubDate": "2025-11-26T09:58:51Z",
        "displayTime": "2025-11-26T09:58:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/c7f6823802519856c48240b8ba6d6d17",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Boston Scientific's Farawave pulsed field ablation catheter.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ic_adTuA89qN1idyZHkibQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/c7f6823802519856c48240b8ba6d6d17.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yr9t4cxFs9lRQMTRx9tuLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/c7f6823802519856c48240b8ba6d6d17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/CMS-Medicare-cardiac-ablation-ASCs/806548/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cms-covers-cardiac-ablation-ambulatory-095851543.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]